|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000545,
umls-concept:C0030705,
umls-concept:C0086153,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C0332256,
umls-concept:C0333348,
umls-concept:C0449438,
umls-concept:C1280500,
umls-concept:C1521739,
umls-concept:C1527249,
umls-concept:C2348609
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-13
|
|
pubmed:abstractText |
The aim of the study was to assess the impact of an eicosapentanoic acid-containing protein and energy dense oral nutritional supplement (EPA-ONS) on nutritional and inflammatory status, quality of life (QOL), plasma phospholipids (PPL) and cytokine profile, tolerance of irinotecan-containing chemotherapy and EPA-ONS in patients with advanced colorectal cancer (CRC) receiving chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0941-4355
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
301-7
|
|
pubmed:meshHeading |
pubmed-meshheading:17021855-Aged,
pubmed-meshheading:17021855-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17021855-Australia,
pubmed-meshheading:17021855-Biological Markers,
pubmed-meshheading:17021855-Body Composition,
pubmed-meshheading:17021855-Camptothecin,
pubmed-meshheading:17021855-Colorectal Neoplasms,
pubmed-meshheading:17021855-Cytokines,
pubmed-meshheading:17021855-Dietary Proteins,
pubmed-meshheading:17021855-Dietary Supplements,
pubmed-meshheading:17021855-Eicosapentaenoic Acid,
pubmed-meshheading:17021855-Energy Intake,
pubmed-meshheading:17021855-Female,
pubmed-meshheading:17021855-Fluorouracil,
pubmed-meshheading:17021855-Humans,
pubmed-meshheading:17021855-Inflammation,
pubmed-meshheading:17021855-Leucovorin,
pubmed-meshheading:17021855-Male,
pubmed-meshheading:17021855-Malnutrition,
pubmed-meshheading:17021855-Middle Aged,
pubmed-meshheading:17021855-Nutritional Status,
pubmed-meshheading:17021855-Nutritional Support,
pubmed-meshheading:17021855-Phospholipids,
pubmed-meshheading:17021855-Quality of Life,
pubmed-meshheading:17021855-Treatment Outcome,
pubmed-meshheading:17021855-Vitamin B Complex
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
|
|
pubmed:affiliation |
Sydney Cancer Centre, Royal Prince Alfred Hospital and Concord Hospital, Sydney, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
